Bavarian Nordic A/S, one of the only companies with a vaccine approved for mpox, has received regulatory approval in Europe ...

The EU's drug regulator has approved Bavarian Nordic's mpox vaccine for use in adolescents aged 12 to 17 years, the company ...

LONDON (Reuters) -Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in ...

Gavi, the Vaccine Alliance, is purchasing 500,000 mpox vaccines from Bavarian Nordic A/S for African countries hardest-hit by ...

The global vaccine group Gavi will buy 500,000 doses of Bavarian Nordic's mpox vaccine, its first purchase of the shot to ...

The World Health Organization and partners on Friday set up a scheme to help bring mpox vaccines, tests and treatments to the ...

While no cases of clade I mpox have yet been detected in the UK, the strain has rapidly spread outside the Democratic ...

Gavi, the Vaccine Alliance and the U.K. government ordered a combined 650,000 doses of Bavarian Nordic’s Jynneos mpox vaccine ...

(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II ...

Bavarian Nordic's mpox vaccine has gained approval for use in adolescents by the EU's drug regulator. This move is seen as ...

It added: Bavarian Nordic A/S (OMX: BAVA) and Gavi, the Vaccine Alliance today announced an advance purchase agreement (APA) ...

The U.K. government has secured over 150,000 doses of the mpox vaccine from Bavarian Nordic A/S (OTC:BVNRY) (OTC:BVNKF) to ...